The Sabin-Aspen Vaccine Science & Policy Group brings together senior leaders across many disciplines to examine some of the most critical vaccine-related issues and drive impactful change. It was launched in 2018 as a joint initiative between Sabin and the Aspen Institute.
Members are influential, creative, out-of-the-box thinkers from the scientific, business, global health and philanthropic fields. Each year, they vigorously probe a single challenge in vaccine development and delivery. They then produce actionable recommendations improving how vaccines are made, distributed and used — as well as evidence-based and cost-effective approaches to immunization.